We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx Sets FDA Meeting to Discuss GMP Problems
Andrx Sets FDA Meeting to Discuss GMP Problems
December 13, 2005
Andrx plans to meet with the FDA on Dec. 14 to discuss manufacturing issues that have stalled the company's drug approvals, Andrx said in a recent filing with the Securities and Exchange Commission (SEC).